Jennison Associates LLC Novo Nordisk A S Call Options Transaction History
Jennison Associates LLC
- $141 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NVO
# of Institutions
1,762Shares Held
340MCall Options Held
11.3MPut Options Held
15.5M-
Bank Of America Corp Charlotte, NC14.8MShares$966 Million0.08% of portfolio
-
Loomis Sayles & CO L P12.4MShares$809 Million1.24% of portfolio
-
Morgan Stanley New York, NY12.3MShares$804 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa11.9MShares$775 Million0.36% of portfolio
-
Fayez Sarofim & CO Houston, TX11.2MShares$732 Million2.01% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $147B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...